| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| GNWGenworth Financial, Inc. | 3.31B | 8.30 | 12.21 | -3.09% | 3.1% | 2.24% | 2.65% | 0.16 |
| MHNCMaiden Holdings North America, Ltd. | 1.58B | 15.87 | -7.90 | -2.92% | -247.48% | -405.36% |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 8.55B | 8.36B | 7.51B | 7.89B | 7.71B | 8.21B | 7.6B | 7.4B | 7.37B | 7.14B |
| Revenue Growth % | -0.02% | -0.02% | -0.1% | 0.05% | -0.02% | 0.07% | -0.07% | -0.03% | -0% | -0.03% |
| Medical Costs & Claims | 8.14B | 7.71B | 7.12B | 7.51B | 6.95B | 7.16B | 6.55B | 6.02B | 7.07B | 6.58B |
| Medical Cost Ratio % | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 404M | 651M | 393M | 382M | 753M | 1.05B | 1.05B | 1.37B | 304M | 558M |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | 24.76% | 0.61% | -0.4% | -0.03% | 0.97% | 0.4% | -0% | 0.31% | -0.78% | 0.84% |
| Operating Expenses | 419M | 331M | 266M | 245M | 231M | 123M | -63M | 7M | 1M | -37M |
| OpEx / Revenue % | - | - | - | - | - | - | - | - | - | - |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Combined Ratio % | - | - | - | - | - | - | - | - | - | - |
| Operating Income | -15M | 320M | 127M | 137M | 522M | 928M | 1.11B | 1.36B | 303M | 595M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | 0.99% | 22.33% | -0.6% | 0.08% | 2.81% | 0.78% | 0.2% | 0.23% | -0.78% | 0.96% |
| EBITDA | 404M | 657M | 393M | 393M | 752M | 1.12B | 1.27B | 1.47B | 421M | 710M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - |
| Interest Expense | 419M | 337M | 266M | 256M | 231M | 195M | 160M | 106M | 118M | 115M |
| Non-Operating Income | -419M | -337M | -266M | -256M | -230M | -195M | -160M | -106M | -118M | -115M |
| Pretax Income | -15M | 320M | 127M | 137M | 521M | 928M | 1.11B | 1.36B | 303M | 595M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - |
| Income Tax | -9M | 358M | -406M | 70M | 139M | 230M | 248M | 319M | 104M | 158M |
| Effective Tax Rate % | - | - | - | - | - | - | - | - | - | - |
| Net Income | -615M | -277M | 817M | 119M | 343M | 178M | 850M | 916M | 76M | 299M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | 0.51% | 0.55% | 3.95% | -0.85% | 1.88% | -0.48% | 3.78% | 0.08% | -0.92% | 2.93% |
| EPS (Diluted) | -1.24 | -0.56 | 1.63 | 0.24 | 1.02 | 1.49 | 1.76 | 1.19 | 0.16 | 0.68 |
| EPS Growth % | 0.51% | 0.55% | 3.91% | -0.85% | 3.25% | 0.46% | 0.18% | -0.32% | -0.87% | 3.25% |
| EPS (Basic) | -1.24 | -0.56 | 1.64 | 0.24 | 1.03 | 1.51 | 1.78 | 1.21 | 0.16 | 0.69 |
| Diluted Shares Outstanding | 497.4M | 498.3M | 501.4M | 500.4M | 509.7M | 511.6M | 514.7M | 511M | 474.9M | 439.4M |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | 106.43B | 104.66B | 105.3B | 100.92B | 101.34B | 105.75B | 99.17B | 89.71B | 90.82B | 86.87B |
| Asset Growth % | -0.04% | -0.02% | 0.01% | -0.04% | 0% | 0.04% | -0.06% | -0.1% | 0.01% | -0.04% |
| Total Investment Assets | 69.13B | 71.57B | 73.39B | 70.11B | 71.23B | 73.65B | 70.38B | 56.62B | 56.93B | 54.79B |
| Long-Term Investments | 61.23B | 63.59B | 65.16B | 61.5B | 60.58B | 63.88B | 60.68B | 46.9B | 47.18B | 45.42B |
| Short-Term Investments | 58.51B | 61.2B | 63.34B | 60.32B | 60.58B | 63.88B | 60.48B | 46.58B | 46.78B | 5.67B |
| Total Current Assets | 5.96B | 2.78B | 2.88B | 2.18B | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash & Equivalents | 5.96B | 2.78B | 2.88B | 2.18B | 3.34B | 2.56B | 1.57B | 1.8B | 2.21B | 2.05B |
| Receivables | 0 | 0 | 0 | 0 | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Current Assets | 0 | 0 | 0 | 0 | -81.02B | -83.26B | -78.86B | -67.38B | -68.02B | -25.38B |
| Goodwill & Intangibles | 357M | 348M | 301M | 347M | 201M | 157M | 143M | 203M | 198M | 197M |
| Goodwill | 14M | 14M | 15M | 13M | 5M | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 343M | 334M | 286M | 334M | 196M | 157M | 143M | 203M | 198M | 0 |
| PP&E (Net) | 196M | 0 | -504M | -736M | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | -19.32B | -22.63B | -25.56B | -22.77B | -60.78B | -64.04B | -60.82B | -47.1B | -47.38B | -45.61B |
| Total Liabilities | 91.79B | 90.19B | 89.97B | 86.73B | 86.71B | 89.93B | 82.91B | 81.33B | 82.48B | 77.44B |
| Total Debt | 6.67B | 4.56B | 4.57B | 4.34B | 3.98B | 3.4B | 1.9B | 1.61B | 1.58B | 1.52B |
| Net Debt | 704M | 1.78B | 1.7B | 2.16B | 644M | 842M | 328M | -188M | -631M | -530M |
| Long-Term Debt | 6.67B | 4.56B | 4.57B | 4.02B | 3.59B | 3.4B | 1.9B | 1.61B | 1.58B | 1.52B |
| Short-Term Debt | 298M | 0 | 597M | 0 | 397M | 0 | 0 | 0 | 0 | 0 |
| Total Current Liabilities | 86.94B | 87.45B | 87.31B | 84.45B | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | -298M | 0 | -597M | 0 | -397M | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | 1000K | 1000K | 1000K | 1000K | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 85.1B | 85.57B | 85.37B | 0 | -3.58B | -3.38B | -1.88B | -1.6B | -1.58B | -1.52B |
| Total Equity | 14.64B | 14.47B | 15.33B | 14.19B | 14.63B | 15.82B | 16.27B | 8.39B | 8.34B | 9.43B |
| Equity Growth % | -0.13% | -0.01% | 0.06% | -0.07% | 0.03% | 0.08% | 0.03% | -0.48% | -0.01% | 0.13% |
| Shareholders Equity | 12.82B | 12.64B | 13.42B | 12.45B | 14.19B | 15.32B | 15.51B | 7.63B | 7.48B | 8.49B |
| Minority Interest | 1.81B | 1.82B | 1.91B | 1.74B | 447M | 502M | 756M | 755M | 855M | 937M |
| Retained Earnings | 564M | 287M | 1.11B | 1.12B | 1.46B | 1.58B | 2.49B | 1.14B | 1.21B | 1.51B |
| Common Stock | 1M | 1M | 1M | 1M | 1M | 1M | 1M | 1M | 1M | 1M |
| Accumulated OCI | 3.01B | 3.09B | 3.03B | 2.04B | 3.43B | 4.42B | 3.86B | -2.61B | -2.56B | -1.64B |
| Return on Equity (ROE) | -0.04% | -0.02% | 0.05% | 0.01% | 0.02% | 0.01% | 0.05% | 0.07% | 0.01% | 0.03% |
| Return on Assets (ROA) | -0.01% | -0% | 0.01% | 0% | 0% | 0% | 0.01% | 0.01% | 0% | 0% |
| Equity / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / Equity | 0.46x | 0.32x | 0.30x | 0.31x | 0.27x | 0.22x | 0.12x | 0.19x | 0.19x | 0.16x |
| Book Value per Share | 29.43 | 29.03 | 30.57 | 28.36 | 28.71 | 30.92 | 31.60 | 16.41 | 17.55 | 21.46 |
| Tangible BV per Share | - | - | - | - | - | - | - | - | - | - |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 1.59B | 1.85B | 2.55B | 1.63B | 2.08B | 1.96B | 437M | 1.05B | 597M | 88M |
| Operating CF Growth % | -0.35% | 0.16% | 0.38% | -0.36% | 0.27% | -0.06% | -0.78% | 1.4% | -0.43% | -0.85% |
| Operating CF / Revenue % | - | - | - | - | - | - | - | - | - | - |
| Net Income | -6M | -38M | 936M | 297M | 519M | 761M | 864M | 1.05B | 76M | 4M |
| Depreciation & Amortization | 546M | 360M | 288M | 269M | 557M | -570M | 0 | 0 | 40M | 130M |
| Stock-Based Compensation | 16M | 32M | 42M | 37M | 27M | 39M | 40M | 37M | 49M | 51M |
| Deferred Taxes | -196M | 145M | -368M | 5M | 139M | 268M | 275M | 315M | 48M | -103M |
| Other Non-Cash Items | -788M | -321M | -363M | -883M | -699M | -646M | -1.76B | -884M | -933M | -618M |
| Working Capital Changes | 2.02B | 1.67B | 2.02B | 1.91B | 1.54B | 2.11B | 1.01B | 535M | 1.32B | 624M |
| Cash from Investing | -404M | -2.12B | -759M | -622M | 1.3B | -1.15B | 896M | 733M | 1.26B | 861M |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 267M | 0 | 0 | 0 | 0 |
| Acquisitions | 273M | 39M | -5M | 0 | 1.4B | -267M | -242M | -460M | -384M | 0 |
| Purchase of Investments | -9.75B | -11.68B | -9.59B | -10.71B | -7.29B | -9.84B | -5.22B | -4.04B | -3.23B | 0 |
| Sale/Maturity of Investments | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 0 |
| Other Investing | -34M | 6M | -157M | -266M | -128M | 387M | -99M | -158M | 215M | 861M |
| Cash from Financing | -42M | -2.93B | -1.77B | -1.62B | -2.22B | -1.51B | -2.42B | -1.55B | -1.44B | -1.11B |
| Dividends Paid | 0 | -138M | -107M | -97M | -87M | 0 | 0 | 0 | 0 | -21M |
| Share Repurchases | 0 | 0 | -33M | 0 | -22M | 0 | 0 | -64M | -296M | -189M |
| Stock Issued | 226M | 0 | 0 | 0 | 22M | 0 | 529M | 0 | 0 | 0 |
| Debt Issuance (Net) | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K |
| Other Financing | 25M | -927M | -1.73B | -1.42B | -1.68B | -1.44B | -1.41B | -1.19B | -1.11B | -831M |
| Net Change in Cash | 1.05B | -3.21B | 91M | -698M | 1.16B | -685M | -1.08B | 228M | 416M | -167M |
| Exchange Rate Effect | -1000K | -1000K | 1000K | -1000K | 1000K | 1000K | 1000K | 0 | 1000K | -1000K |
| Cash at Beginning | 4.92B | 5.99B | 2.78B | 2.88B | 2.18B | 3.34B | 2.66B | 1.57B | 1.8B | 2.21B |
| Cash at End | 5.96B | 2.78B | 2.88B | 2.18B | 3.34B | 2.66B | 1.57B | 1.8B | 2.21B | 2.05B |
| Free Cash Flow | 1.59B | 1.85B | 2.55B | 1.63B | 2.08B | 2.23B | 437M | 1.05B | 597M | 88M |
| FCF Growth % | -0.35% | 0.16% | 0.38% | -0.36% | 0.27% | 0.07% | -0.8% | 1.4% | -0.43% | -0.85% |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - |
| FCF per Share | 3.2 | 3.72 | 5.09 | 3.26 | 4.08 | 4.35 | 0.85 | 2.05 | 1.26 | 0.2 |
| Metric | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Combined Ratio | 100.18% | 96.17% | 98.31% | 98.26% | 93.23% | 88.7% | 85.37% | 81.54% | 95.89% | 91.67% |
| Medical Cost Ratio | 95.27% | 92.22% | 94.77% | 95.16% | 90.23% | 87.2% | 86.2% | 81.45% | 95.88% | 92.19% |
| Return on Equity (ROE) | -3.91% | -1.9% | 5.48% | 0.81% | 2.38% | 1.17% | 5.3% | 7.43% | 0.91% | 3.37% |
| Return on Assets (ROA) | -0.56% | -0.26% | 0.78% | 0.12% | 0.34% | 0.17% | 0.83% | 0.97% | 0.08% | 0.34% |
| Equity / Assets | 13.75% | 13.82% | 14.56% | 14.06% | 14.44% | 14.96% | 16.4% | 9.35% | 9.18% | 10.86% |
| Book Value / Share | 29.43 | 29.03 | 30.57 | 28.36 | 28.71 | 30.92 | 31.6 | 16.41 | 17.55 | 21.46 |
| Debt / Equity | 0.46x | 0.32x | 0.30x | 0.31x | 0.27x | 0.22x | 0.12x | 0.19x | 0.19x | 0.16x |
| Revenue Growth | -2.07% | -2.16% | -10.16% | 5.02% | -2.33% | 6.57% | -7.46% | -2.67% | -0.34% | -3.09% |
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Long Term Care Insurance | - | - | - | - | - | - | - | - | 2.46B | 2.31B |
| Long Term Care Insurance Growth | - | - | - | - | - | - | - | - | - | -6.21% |
| Life and Annuities | - | - | - | - | - | - | - | - | - | 817M |
| Life and Annuities Growth | - | - | - | - | - | - | - | - | - | - |
| Life Insurance | - | - | - | - | - | - | - | - | - | 704M |
| Life Insurance Growth | - | - | - | - | - | - | - | - | - | - |
| Corporate and Other | 25M | 12M | 8M | 8M | 8M | 7M | 6M | 6M | 9M | 11M |
| Corporate and Other Growth | - | -52.00% | -33.33% | 0.00% | 0.00% | -12.50% | -14.29% | 0.00% | 50.00% | 22.22% |
| Fixed Annuities | - | - | - | - | - | - | - | - | - | 7M |
| Fixed Annuities Growth | - | - | - | - | - | - | - | - | - | - |
| U S Life Insurance | - | - | - | - | - | - | 2.45B | 2.77B | - | - |
| U S Life Insurance Growth | - | - | - | - | - | - | - | 13.00% | - | - |
| Enact Holdings Inc | - | - | - | - | - | - | 975M | 940M | - | - |
| Enact Holdings Inc Growth | - | - | - | - | - | - | - | -3.59% | - | - |
| Runoff | 1M | - | - | - | - | - | - | - | - | - |
| Runoff Growth | - | - | - | - | - | - | - | - | - | - |
| Us Life Insurance | 3.13B | 2.67B | 2.92B | 2.87B | 2.86B | 2.86B | - | - | - | - |
| Us Life Insurance Growth | - | -14.64% | 9.44% | -1.88% | -0.21% | -0.10% | - | - | - | - |
| US Mortgage Insurance | - | - | - | - | 856M | 971M | - | - | - | - |
| US Mortgage Insurance Growth | - | - | - | - | - | 13.43% | - | - | - | - |
| Us Mortgage Insurance | 602M | 660M | 695M | 746M | - | - | - | - | - | - |
| Us Mortgage Insurance Growth | - | 9.63% | 5.30% | 7.34% | - | - | - | - | - | - |
| Canada Mortgage Insurance | 466M | 481M | 519M | 525M | - | - | - | - | - | - |
| Canada Mortgage Insurance Growth | - | 3.22% | 7.90% | 1.16% | - | - | - | - | - | - |
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Australia Mortgage Insurance | - | - | - | - | 312M | 274M | - | - | - | - |
| Australia Mortgage Insurance Growth | - | - | - | - | - | -12.18% | - | - | - | - |
| UNITED STATES | 7.48B | 7.27B | 7.55B | - | - | - | - | - | - | - |
| UNITED STATES Growth | - | -2.85% | 3.80% | - | - | - | - | - | - | - |
| CANADA | 564M | 645M | 780M | - | - | - | - | - | - | - |
| CANADA Growth | - | 14.36% | 20.93% | - | - | - | - | - | - | - |
| Other Countries | 27M | 14M | 9M | - | - | - | - | - | - | - |
| Other Countries Growth | - | -48.15% | -35.71% | - | - | - | - | - | - | - |
| AUSTRALIA | 474M | 440M | -40M | - | - | - | - | - | - | - |
| AUSTRALIA Growth | - | -7.17% | -109.09% | - | - | - | - | - | - | - |
Genworth Financial, Inc. (GNW) has a price-to-earnings (P/E) ratio of 12.2x. This may indicate the stock is undervalued or faces growth challenges.
Genworth Financial, Inc. (GNW) saw revenue decline by 3.1% over the past year.
Yes, Genworth Financial, Inc. (GNW) is profitable, generating $220.0M in net income for fiscal year 2024 (4.2% net margin).
Yes, Genworth Financial, Inc. (GNW) pays a dividend with a yield of 0.58%. This makes it attractive for income-focused investors.
Genworth Financial, Inc. (GNW) has a return on equity (ROE) of 3.4%. This is below average, suggesting room for improvement.
Genworth Financial, Inc. (GNW) has a combined ratio of 91.7%. A ratio below 100% indicates underwriting profitability.